Multiple Myeloma
Advertisement
Dr. Ailawadhi explained how oncologists should consider racial differences when approaching clinical care.
Inpatient treatment comprised 48% of medical costs in patients with renal impairment.
Patients with multiple myeloma in the US Military Health System had significantly better survival rates.
Race was associated with the dollar amount patients were willing to pay for treatment each month.
Obesity significantly increases the risk of multiple myeloma, especially in Black populations.
These factors may drive disparities in care for Black patients with multiple myeloma.
A new study shows why it's important for nurses to be aware of how social determinants of health affect medication adherence.
It's important for nurses to recognize opportunities to address racial disparities in hospice use and access.
Clinical trial knowledge is related to the likelihood of participation.
More than 70% of patients aged 70 years and older with multiple myeloma prioritized functional independence as important.
Stem cell transplant utilization remains suboptimal and marked by racial-ethnic disparities.
The study results underscore the importance of equitable treatment access for all patients.
New research shows there is increasing racial disparity in treatment utilization over time among patients with MM.
A new study shows why it’s critical for nurses to be aware of how social determinants of health affect patients with MM.
A team developed a community-wide MM screening program for those who are Black and 50 years of age or older.
Non-Hispanic Black and White patients with MM had comparable links between risk factors and survival in the real world.
Heart failure with preserved ejection fraction (HFpEF) had worse mortality and acute kidney injury versus HF with reduced EF.
HSCT in the first line of therapy achieved consistent survival benefits across subgroups of patients with multiple myeloma.
In hospitalizations for multiple myeloma, mortality and disability rates were disparately impacted by socioeconomic status.
Hispanic patients with multiple myeloma had lower overall response rates to idecabtagene vicleucel.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.